243 related articles for article (PubMed ID: 16158445)
1. Multiple dose pharmacokinetics of caffeine administered in chewing gum to normal healthy volunteers.
Syed SA; Kamimori GH; Kelly W; Eddington ND
Biopharm Drug Dispos; 2005 Dec; 26(9):403-9. PubMed ID: 16158445
[TBL] [Abstract][Full Text] [Related]
2. The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers.
Kamimori GH; Karyekar CS; Otterstetter R; Cox DS; Balkin TJ; Belenky GL; Eddington ND
Int J Pharm; 2002 Mar; 234(1-2):159-67. PubMed ID: 11839447
[TBL] [Abstract][Full Text] [Related]
3. Multiple caffeine doses maintain vigilance during early morning operations.
Kamimori GH; Johnson D; Thorne D; Belenky G
Aviat Space Environ Med; 2005 Nov; 76(11):1046-50. PubMed ID: 16313140
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
5. Effects of caffeine in chewing gum on mood and attention.
Smith A
Hum Psychopharmacol; 2009 Apr; 24(3):239-47. PubMed ID: 19330801
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
7. Comparative bioavailability of single-dose methylphenidate from a multilayer-release bead formulation and an osmotic system: a two-way crossover study in healthy young adults.
Reiz JL; Donnelly GA; Michalko K
Clin Ther; 2008 Jan; 30(1):59-69. PubMed ID: 18343243
[TBL] [Abstract][Full Text] [Related]
8. Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine.
Wesensten NJ; Belenky G; Kautz MA; Thorne DR; Reichardt RM; Balkin TJ
Psychopharmacology (Berl); 2002 Jan; 159(3):238-47. PubMed ID: 11862356
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
Lim KS; Kim JR; Choi YJ; Shin KH; Kim KP; Hong JH; Cho JY; Shin HS; Yu KS; Shin SG; Kwon OH; Hwang DM; Kim JA; Jang IJ
Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837
[TBL] [Abstract][Full Text] [Related]
11. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
12. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
Darwish M; Chang S; Hellriegel ET
Clin Ther; 2009 Jan; 31(1):108-14. PubMed ID: 19243711
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent caffeine pharmacokinetics during severe sleep deprivation in humans.
Kamimori GH; Lugo SI; Penetar DM; Chamberlain AC; Brunhart GE; Brunhart AE; Eddington ND
Int J Clin Pharmacol Ther; 1995 Mar; 33(3):182-6. PubMed ID: 7599918
[TBL] [Abstract][Full Text] [Related]
14. Comparison of systemic exposure to nemifitide following two methods of subcutaneous administration to healthy volunteers.
Nicolau G; Feighner JP; Stout R; Hlavka J; Gutierrez M; Ciric S; Freed J
Biopharm Drug Dispos; 2005 Dec; 26(9):379-85. PubMed ID: 16130176
[TBL] [Abstract][Full Text] [Related]
15. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
[TBL] [Abstract][Full Text] [Related]
16. Caffeine-herbal ephedra combination increases resting energy expenditure, heart rate and blood pressure.
Vukovich MD; Schoorman R; Heilman C; Jacob P; Benowitz NL
Clin Exp Pharmacol Physiol; 2005; 32(1-2):47-53. PubMed ID: 15730434
[TBL] [Abstract][Full Text] [Related]
17. The effects of 600 mg of slow release caffeine on mood and alertness.
Sicard BA; Perault MC; Enslen M; Chauffard F; Vandel B; Tachon P
Aviat Space Environ Med; 1996 Sep; 67(9):859-62. PubMed ID: 9025802
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
[TBL] [Abstract][Full Text] [Related]
19. Multiple-dose pharmacokinetics of intravenous telavancin in healthy male and female subjects.
Wong SL; Barriere SL; Kitt MM; Goldberg MR
J Antimicrob Chemother; 2008 Oct; 62(4):780-3. PubMed ID: 18586659
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects.
Christopher R; Covington P; Davenport M; Fleck P; Mekki QA; Wann ER; Karim A
Clin Ther; 2008 Mar; 30(3):513-27. PubMed ID: 18405789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
